DE3870314D1 - Mittel zur aeusserlichen anwendung und verwendung dieses mittels. - Google Patents

Mittel zur aeusserlichen anwendung und verwendung dieses mittels.

Info

Publication number
DE3870314D1
DE3870314D1 DE8888109207T DE3870314T DE3870314D1 DE 3870314 D1 DE3870314 D1 DE 3870314D1 DE 8888109207 T DE8888109207 T DE 8888109207T DE 3870314 T DE3870314 T DE 3870314T DE 3870314 D1 DE3870314 D1 DE 3870314D1
Authority
DE
Germany
Prior art keywords
agent
external
external use
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8888109207T
Other languages
German (de)
English (en)
Inventor
Masatoshi Arima
Hiroaki Nishizawa
Keiji Takeuchi
Hiroshi Deura
Keiichiro Ishida
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lion Corp
Original Assignee
Lion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lion Corp filed Critical Lion Corp
Application granted granted Critical
Publication of DE3870314D1 publication Critical patent/DE3870314D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cosmetics (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DE8888109207T 1987-06-09 1988-06-09 Mittel zur aeusserlichen anwendung und verwendung dieses mittels. Expired - Lifetime DE3870314D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP14350787 1987-06-09
JP63070396A JPS6479103A (en) 1987-06-09 1988-03-24 External preparation

Publications (1)

Publication Number Publication Date
DE3870314D1 true DE3870314D1 (de) 1992-05-27

Family

ID=26411561

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8888109207T Expired - Lifetime DE3870314D1 (de) 1987-06-09 1988-06-09 Mittel zur aeusserlichen anwendung und verwendung dieses mittels.

Country Status (5)

Country Link
US (1) US5073545A (https=)
EP (1) EP0294808B1 (https=)
JP (1) JPS6479103A (https=)
DE (1) DE3870314D1 (https=)
ES (1) ES2032899T3 (https=)

Families Citing this family (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3824350A1 (de) * 1988-06-09 1989-12-21 Eau De Cologne & Parfuemerie Fabrik 4711 Kosmetisches und/oder hautpflegendes mittel mit pflanzlichem wirkstoffanteil
JP2602070B2 (ja) * 1988-08-12 1997-04-23 株式会社資生堂 化粧料
US5288485A (en) * 1989-08-31 1994-02-22 Kao Corporation Vasodilating agent
ES2049661B1 (es) * 1992-10-09 1994-11-01 Imbeal S A Lab Compuesto anticelulitico y proccedimiento de obtencion del mismo.
WO1994018994A1 (en) * 1993-02-23 1994-09-01 Pharmakon Usa, Inc. Therapeutic herbal composition
CA2155181A1 (en) * 1993-12-15 1995-06-22 Keiichiro Okabe Cosmetic
US6068834A (en) 1994-03-04 2000-05-30 The Procter & Gamble Company Skin lightening compositions
DE69512509T2 (de) * 1995-02-03 2000-05-31 Fideline, Le Rieu Neuf Eigenschaften von Gesichtpheromonen von Katzen
FR2730408B1 (fr) * 1995-02-09 1997-09-05 Hanna Claude Compositions a activite depigmentante ainsi que leurs applications
US6066312A (en) * 1996-07-16 2000-05-23 Lion Corporation Topical composition for application to the skin containing an ellagic acid-based compound or salt thereof
KR19980027092A (ko) * 1996-10-14 1998-07-15 성재갑 대극속 식물 추출물을 함유한 피부 미백용 조성물
FR2757391B1 (fr) * 1996-12-20 1999-03-12 Dior Christian Parfums Utilisation d'un extrait de la plante terminalia, dans les domaines cosmetique et pharmaceutique, notamment dermatologique
EP0965596A1 (en) * 1996-12-27 1999-12-22 Daiichi Pharmaceutical Co., Ltd. Method for elevating the concentration of free insulin-like growth factor
GB9704904D0 (en) * 1997-03-10 1997-04-30 Riley Fletcher Foundation The Essential oil composition
US5916576A (en) * 1997-05-30 1999-06-29 Amway Corporation Method of scavenging free radicals using orange extract
FR2768927B1 (fr) * 1997-10-01 2000-01-21 Lvmh Rech Utilisation de l'acide ellagique, de ses sels, de ses complexes metalliques, de ses derives mono- ou poly-ethers, mono- ou poly-acyles dans le domaine de la cosmetique et de la pharmacie, notamment de la dermatologie
US6017551A (en) * 1997-12-11 2000-01-25 Riley; George E. Topical salve
JP2000143479A (ja) * 1998-11-05 2000-05-23 Kao Corp 美白化粧料
JP2000281555A (ja) * 1999-03-26 2000-10-10 Pentapharm Japan Kk 皮膚外用剤
US6800292B1 (en) 1999-04-22 2004-10-05 Howard Murad Pomegranate fruit extract compositions for treating dermatological disorders
US6630163B1 (en) 1999-04-22 2003-10-07 Howard Murad Method of treating dermatological disorders with fruit extracts
US6210701B1 (en) * 1999-04-30 2001-04-03 Healthcomm International, Inc. Medical food for treating inflammation-related diseases
JP2000319159A (ja) * 1999-05-10 2000-11-21 Nonogawa Shoji Kk 皮膚外用剤
JP3523829B2 (ja) * 1999-09-01 2004-04-26 甫 鳥本 芝生の病害虫防除剤、その製造方法及び防除方法
CA2282185A1 (en) 1999-09-10 2001-03-10 Warren Steck Oenothein medicaments
FR2802415B1 (fr) * 1999-12-20 2002-07-19 Oreal Composition cosmetique comprenant le n-ethyloxycarbonyl-4- amino-phenol et l'arbutine ou ses derives et/ou l'acide ellagique ou ses derives
US6365143B1 (en) * 2000-04-03 2002-04-02 Larry D. Lundmark Cleansing composition and method for removing chemically bound residues and mineral deposits from hair
JP4992164B2 (ja) * 2000-04-19 2012-08-08 日油株式会社 化粧料組成物
FR2809004B1 (fr) * 2000-05-18 2002-12-27 Oreal Utilisation de l'acide ellagique comme agent cosmetique anti-pollution
US20040092494A9 (en) * 2000-08-30 2004-05-13 Dudley Robert E. Method of increasing testosterone and related steroid concentrations in women
US6503894B1 (en) 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
JP4880816B2 (ja) * 2000-12-15 2012-02-22 株式会社ヤクルト本社 皮膚老化防止剤
US20020127256A1 (en) * 2001-03-01 2002-09-12 Howard Murad Compositions and methods for treating dermatological disorders
WO2002087527A1 (en) * 2001-04-25 2002-11-07 Chaim Werdyger Insect repellent
US7147876B2 (en) * 2001-08-13 2006-12-12 Michael Hargreaves Riley Compositions for removal of toxins
JP2003063925A (ja) * 2001-08-23 2003-03-05 Kose Corp 皮膚外用剤
DE10161149B4 (de) * 2001-12-12 2007-03-08 Ursapharm Arzneimittel Gmbh & Co. Kg Verwendung von Heparin-haltigem Ophthalmikum
DE10161110A1 (de) * 2001-12-12 2003-06-26 Ursapharm Arzneimittel Gmbh Pharmazeutische Zusammensetzung zur ophthalmologischen und rhinologischen Anwendung
US6649150B2 (en) * 2002-04-11 2003-11-18 Em Industries Skin-lightening
JP3737979B2 (ja) * 2002-03-15 2006-01-25 株式会社コーセー 美白化粧料
JP2003267818A (ja) * 2002-03-15 2003-09-25 Kose Corp 美白化粧料
US20040146539A1 (en) * 2003-01-24 2004-07-29 Gupta Shyam K. Topical Nutraceutical Compositions with Selective Body Slimming and Tone Firming Antiaging Benefits
US20040156797A1 (en) * 2003-02-10 2004-08-12 Ghada Haddad De' SaLa
US7097064B2 (en) * 2004-01-28 2006-08-29 Meyer Intellectual Properties Limited Double wall cooking vessel
TWI415618B (zh) * 2004-01-30 2013-11-21 Suntory Holdings Ltd 美白劑
US8288362B2 (en) * 2004-05-07 2012-10-16 S.K. Pharmaceuticals, Inc. Stabilized glycosaminoglycan preparations and related methods
WO2005110439A2 (en) * 2004-05-07 2005-11-24 S.K. Pharmaceuticals, Inc. Stabilized hyaluronan preparations and related methods
JP4726505B2 (ja) * 2005-01-31 2011-07-20 サントリーホールディングス株式会社 皮膚外用剤及び皮膚の美白方法
GEP20125432B (en) 2005-10-12 2012-03-26 Unimed Pharmaceuticals Llc Improved testosterone gel and use thereof
FR2902324B1 (fr) * 2006-06-20 2009-04-03 Oreal Utilisation d'acide ellagique pour le traitement de la canitie
EP2455134B1 (en) 2007-04-19 2016-05-11 Mary Kay, Inc. Magnolia extract containing compositions
DE102008008540A1 (de) * 2008-02-07 2009-08-13 Beiersdorf Ag Hautpflegezubereitung zur Pflege von gestresster Haut
CA2757342C (en) * 2008-04-01 2017-05-09 Biopharmacopae Design International Inc. Extracts from plants of the tsuga genus and uses thereof in the treatment of inflammation, irritation and/or infection
KR101536224B1 (ko) * 2008-09-05 2015-07-15 주식회사 바이오랜드 굴피나무 열매 추출물을 함유하는 피부 미백 조성물
FR2939674B1 (fr) * 2008-12-17 2010-12-10 Oreal Dispersion aqueuse d'acide ellagique et son utilisation en cosmetique
FR2956809B1 (fr) * 2010-03-01 2014-09-26 Oreal Composition comprenant de l'acide ellagique et un tensioactif cationique particulier et son utilisation en cosmetique
FR2956808B1 (fr) 2010-03-01 2012-05-25 Oreal Utilisation de l'acide ellagique comme agent anti-pelliculaire.
FR2956811B1 (fr) 2010-03-01 2012-05-25 Oreal Composition cosmetique anti-pelliculaire a base d'acide ellagique ou d'un de ses derives et d'un second compose actif different dans un rapport ponderal particulier.
EP2542216A2 (en) 2010-03-01 2013-01-09 L'Oréal Cosmetic composition based on ellagic acid or a derivative thereof and on a particular mixture of surfactants
FR2956812B1 (fr) 2010-03-01 2013-03-08 Oreal Composition cosmetique a base d'acide ellagique ou d'un de ses derives et d'un extrait de bacterie.
FR2959666B1 (fr) 2010-05-07 2012-07-20 Oreal Composition cosmetique moussante a base d'acide ellagique ou d'un de ses derives et d'huile essentielle.
JP5912678B2 (ja) * 2012-03-07 2016-04-27 花王株式会社 バイオフィルム除去剤
CA3291904A1 (en) 2012-06-27 2026-03-02 Amazentis Sa Enhancing autophagy or increasing longevity by administration of urolithins or precursors thereof
FR3001147B1 (fr) 2013-01-18 2015-07-17 Oreal Composition cosmetique solide souple, comprenant des tensioactifs anio-niques et des particules solides, et procede de traitement cosmetique
FR3001145B1 (fr) 2013-01-18 2015-07-17 Oreal Composition cosmetique solide souple comprenant des tensioactifs anio-niques et des polyols, et procede de traitement cosmetique
FR3001144B1 (fr) 2013-01-18 2015-07-17 Oreal Composition cosmetique solide souple comprenant des tensioactifs anioniques et des agents conditionneurs polymeriques, et procede de traitement cosmetique
US20160000697A1 (en) * 2013-03-14 2016-01-07 Avon Products, Inc. Gracilaria textorii extracts and methods of use
DE102014111357B4 (de) 2014-08-08 2018-09-27 Minasolve Germany Gmbh Ellagsäure enthaltende Partikel und Verfahren zu ihrer Herstellung
WO2018026859A1 (en) 2016-08-01 2018-02-08 Kedrowski Brant Lawrence Skin lightening compounds from fruit seed extracts
JP7063567B2 (ja) * 2017-10-02 2022-05-09 ロレアル エラグ酸化合物を含む組成物
CN113244224B (zh) * 2021-05-27 2022-06-03 中南林业科技大学 一种鞣花酸缓释凝胶及其制备方法和应用
GB202308224D0 (en) 2023-06-01 2023-07-19 Amazentis Sa Formulation

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1478523A (fr) * 1966-03-11 1967-04-28 Prod Chim Et Celluloses Rey Procédé de purification de l'acide ellagique
US3576007A (en) * 1967-01-16 1971-04-20 Pfizer Water soluble salts of ellagic acid
US3694557A (en) * 1970-10-23 1972-09-26 Amazon Natural Drug Co The Anti-inflammation compositions containing taspine or acid salts thereof and method of use
JPS57145880A (en) * 1981-03-06 1982-09-09 Hokuriku Seiyaku Co Ltd Production of 3,3',4-tri-o-methylellagic acid
JPS5838209A (ja) * 1981-08-29 1983-03-05 Sunstar Inc タンニン配合皮膚外用剤組成物
FR2543434B1 (fr) * 1983-04-01 1986-03-14 Muller International Sarl Alba Composition et procede pour la teinture du systeme pileux.
JPS60202806A (ja) * 1984-03-26 1985-10-14 Sansho Seiyaku Kk 色白化粧料

Also Published As

Publication number Publication date
ES2032899T3 (es) 1993-03-01
US5073545A (en) 1991-12-17
EP0294808A1 (en) 1988-12-14
JPS6479103A (en) 1989-03-24
EP0294808B1 (en) 1992-04-22
JPH0552806B2 (https=) 1993-08-06

Similar Documents

Publication Publication Date Title
DE3870314D1 (de) Mittel zur aeusserlichen anwendung und verwendung dieses mittels.
DE68928051D1 (de) Behandlung von humanem Kollagen und Verwendung als Auto-Implantat
DE68912302D1 (de) Härtendes material für medizinischen und dentalen gebrauch.
NO873695D0 (no) Dentalt implantat av skruetypen og fremgangsmaate for bruk av samme.
LV10654A (lv) Diagnostikas kompozicijas iegusanas panemiens un diagnostikas kompozicijas pielietojums
GB2091100B (en) Oily composition for the treatment of keratin substances and the skin
DE3669997D1 (de) Rollstuhl und anwendungsweise.
ATA380384A (de) Verwendung von solarfiltern zur stabilisierung und verbesserung der hautvertraeglichkeit von benzoylperoxyd enthaltenden zubereitungen zur lokalen aknebehandlung
DE3867710D1 (de) Zusammensetzung zur anwendung auf haare und kopfhaut.
ATA232387A (de) Mittel zur zahnpflege
DE68910113D1 (de) Wachstuminhibierendes mittel und dessen verwendung.
FI906183A7 (fi) Kosmeettisia ja ihonkäsittelyseoksia
KR880700673A (ko) 골손상 치료용방법 및 조성물
IT8868118A0 (it) Composizione e procedimento per il trattamento e la cura dei capelli
DE3584370D1 (de) Verwendung von podophyllotoxin und dessen derivaten.
DE3782028D1 (de) Verwendung von ketonderivaten zur behandlung von bewusstseinsstoerungen.
DE69003598D1 (de) Melanogenese-inhibitierendes mittel zur aeusserlichen anwendung.
DE69214299D1 (de) Verwendung von alkylpolyglycosiden und/oder 0-acylierte glukosederivate zur behandlung des haarausfalls
AU4805085A (en) Mittel zur behandlung von androgenisierungserscheinungen und verwendung von antiandrogenen zur herstellung des mittels
ATE116368T1 (de) Vektoren und verbindungen zur expression von zymogen-formen von menschlichem protein c.
DE3871712D1 (de) Suspensionen und verwendung dieser suspensionen.
DE3677910D1 (de) Haarwuchspraeparat das vasoaktives darmpolypeptid als aktives mittel enthaelt und verfahren zur anwendung dieses praeparats zum foerdern des haarwuchses.
ATE238795T1 (de) Verwendung von aminothiazolen zur wund- und hautbehandlung
DE68917616D1 (de) Demulgator-Zusammensetzungen und Herstellungsmethode und Verwendung.
FI890810A7 (fi) Palovammojen käsittely

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8320 Willingness to grant licences declared (paragraph 23)